Pseudomonas Aeruginosa Treatment

Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States    DocWire News

Pseudomonas Aeruginosa Pneumonia Pipeline Review, H2 2020 - Therapeutic Assessment of 4 Companies & 7 Drug Profiles - ResearchAndMarkets.com    Galveston County Daily News

The Impact of Rapid Diagnostic Testing and Biomarkers on Antimicrobial Stewardship: Deriving Their Optimal Benefit    Infectious Disease Special Edition

Trial of Oral CB-280 for Chronic Lung Infections in CF Enrolling...    Cystic Fibrosis News Today

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue US Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy    BioSpace

IDEXX receives UK Acceptance for Legionella pneumophila testing    Cleanroom Technology

Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update    P&T Community

Phase 1b Study of CB-280 for CF Chronic Lung Infections May Open...    Cystic Fibrosis News Today

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy    The Lancet

New antibiotic fights drug-resistant bacteria without notable toxic side-effects    News-Medical.Net

Armata Pharmaceuticals to Participate in the Maxim Group M-Vest Infectious Disease Virtual Conference: The Renaissance of the Anti-Infective Sector    P&T Community

Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria    Science Advances

Mineral Independent    Clark Fork Valley Press

Evolution of bacterial movement revealed    Phys.org

Armata Pharmaceuticals to Participate in the Maxim Group M-Vest Infectious Disease Virtual Conference: The Renaissance of the Anti-Infective Sector    P&T Community

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections With Limited Treatment Options    Kankakee Daily Journal

Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    Business Wire

Daily Inter Lake    Daily Inter Lake

University of Montana researchers work on COVID-19 vaccine    Phys.Org

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections With Limited Treatment Options    Kankakee Daily Journal